Jellox Biotech, Inc.

Jellox Biotech, Inc. — FDA 510(k) Submissions

Jellox Biotech, Inc. has submitted 1 FDA 510(k) premarket notifications since 2024, of which 1 received clearance as substantially equivalent to a predicate device.

The company's most frequent device categories include Digital Pathology Image Viewing And Management Software . Use the specialty filter in the sidebar to narrow results.